Zometa & Osteonecrosis of jaw

24.5%

of users reported Osteonecrosis of jaw

67.2%

also reported Severe reaction

62.3%

are women

Severe reaction

67.2%

Hospitalization

21.5%

Disability

9.5%

Death

1.7%

Life-threatening condition

0.1%

Zometa: general information

20 - 29 years

0.2%

30 - 39 years

1.7%

40 - 49 years

10.7%

50 - 59 years

19.4%

60 - 69 years

31.5%

70 - 79 years

26.4%

80 - 89 years

10.1%